Home' Australian Pharmacist : Australian Pharmacist July 2012 Contents 520 Australian Pharmacist July 2012 I ©Pharmaceutical Society of Australia Ltd.
Sinclair to chair for AACP
By Andrew Daniels
Paul Sinclair will Chair the Australian
Association of Consultant Pharmacy
(AACP) Board for the next two years.
Addressing the 320 delegates to
the AACP's ConPharm conference
last month, outgoing Chair Debbie
Rigby congratulated Mr Sinclair on
She said, 'Paul's strategic insight into
community pharmacy practice and the
5th Community Pharmacy Agreement
will enhance the opportunities for better
integration of HMRs and RMMRs into
community pharmacies and across the
continuum of care.'
Addressing the conference Mr Sinclair
said, 'I look forward to the challenge of
chairing the AACP for the next two years
and I thank Debbie for her dedication and
commitment to AACP.
'Debbie has been a member of the Board
for 11 years and has played a key role in
the evolution of consultant pharmacy
services. Her contribution to AACP
policies and the accreditation processes
has ensured that the AACP remains the
pre-eminent credentialing body for
'The landscape in community pharmacy
is changing rapidly, with traditional
business models under increasing
pressure and market forces making
pharmacists look closely at how they run
their businesses and how they can be run
more e ciently.
'Delivery of professional services by both
community pharmacy and consultant
pharmacists is now well established via
the community pharmacy agreements.
Services such as home medication
reviews and residential medication
management reviews play a vital
part in the health management of
Mr Sinclair said HMR and RMMR funding
through the Fifth Community Pharmacy
Agreement is xed and limited, like all
other areas of the Agreement.
'The VALMER Report highlighted that
some reviews that were conducted
may not be cost e ective and patients
could be more appropriately targeted.
The challenge going forward for all of
us will be to keep these programs viable
'The change to include direct referral
from GPs to accredited pharmacists
last October represents a signi cant
opportunity for many associates.
With this opportunity, however, comes
the responsibility to utilise it in a manner
which respects the business rules and the
intent of the program,' he said.
Mr Sinclair said that the AACP and all
of its associates form a strong strategic
platform for the Pharmacy Guild.
'Going forward into a sixth and seventh
community pharmacy agreement, having
the ability to deliver credentials which
will enhance the provision of future
programs and service via a workforce
with a proven record of delivery and
patient-centred outcomes will strengthen
the case for more funding for more
Appointed to the AACP Board as one
of the four Guild-nominated directors
in March 2009, Paul Sinclair is also Vice
President of the NSW Branch of the
Pharmacy Guild (PGA) and a PGA National
Councillor. He is a practising community
pharmacist with more than 30 years
experience, having owned pharmacies
in south west Sydney, the Southern
Highlands and the Central Coast of
NSW. He was Chairperson of the 4CPA
Professional Programs and Services
Advisory Committee (PPSAC) which
oversaw the expenditure of $568m for
professional services in that agreement,
and is currently a member of the 5CPA
Consultative Committee (ACC).
Hospital referral pathway
By Andrew Daniels
The introduction of a hospital referral
pathway for home medicines reviews
(HMRs) will not happen as originally
planned on 1 July.
However, the number of HMRs being
completed each month has increased by
2,000 in the past year.
In her nal address as AACP Chair, Debbie
Rigby told ConPharm delegates that there
are now 2,125 accredited pharmacists
and 759 candidates working through the
She said that HMRs and RMMRs are
the only professional services that
have proven sustainable through the
Community Pharmacy Agreement.
'HMRs are averaging around 7,000 per
month, up from around 5,000 this time
last year. GP claims for the last few
months for RMMRs are approximately
5,500, showing little impact from the
change to collaborative only RMMRs,' Ms
'It is always pleasing to hear consumers
and consumer groups promoting the
value of HMRs to help people better
manage their medicines and, in the
catch phrase of NPS, be medicinewise.
That value should not be compromised.
'October 1 last year saw the welcome
introduction of direct referrals from GPs
to accredited pharmacists. Discussions
on the HMR hospital referral pathway
are progressing and the Department
has told me the input received through
the submissions process has resolved a
number of questions,' she said.
However, given the complexity of the
issues and the number of stakeholders
involved, a July 1 implementation date
would not occur and the Department
intended to hold a meeting with peak
organisations to nalise the proposed
hospital referral pathway in late June.
Ms Rigby highlighted the need for best
practice for HMRs and RMMRs. She said
best practice acknowledged that:
• HMRs should be conducted in the
Paul Sinclair and Debbie Rigby
Links Archive Australian Pharmacist June 2012 Australian Pharmacist August 2012 Navigation Previous Page Next Page